Home > News > UML nanotech research spawns new biopharm company
July 12th, 2006
UML nanotech research spawns new biopharm company
Abstract:
UMass Lowell's Louis Petrovic describes the current nanotechnology boom in three words: "Small is good." But the university is hoping that Encapsion, a new biopharmaceutical company spawned by research at UMass Lowell, will be big -- very big.
Source:
lowellsun.com
Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||